CSPS Symposium and Call For Abstracts/Posters

Sandra Hutt sandra.hutt at ualberta.ca
Wed Apr 7 10:30:27 EST 1999


> 2nd Annual Symposium of the Canadian Society for Pharmaceutical
> Sciences (CSPS)
> 
> Friday, August 27th, 1999 & Saturday, August 28th, 1999
> 
> Le Centre Sheraton Hotel, Montreal, Quebec, Canada
> 
> "Exploring Human Diversity in Drug Development and Pharmacotherapy"
> 
> Programme Topics
> 
> 	Pharmaceutical Research and Drug Development in the New
> Millennium.
> 
> 	New Advances in Human Diversity.
> 	This section will highlight important new advances in our
> understanding of individual factors involved in pharmacokinetic and
> pharmacodynamic variability. Speakers will focus on the contributing
> role of age, gender, disease and genetic polymorphism in intersubject
> variability.
> 
> 	The New Era of Pharmacogenomics
> 	This section will concentrate on methods involved in
> pharmacogenetic studies as well as the clinical application of
> pharmacogenetic research. Speaker topics will introduce the audience
> to pharmacogenetics, pharmacogenomics, proteomics and bioinformation
> sources in drug development, subject selection and clinical study
> design. 
> 
> 	Subject Selection in Drug Testing.
> 	This section will provide an in depth discussion on subject
> selection in clinical trials with a focus on regulatory aspects.
> Issues pertaining to inter- and intra- subject variability in
> bioequivalency studies and current views on the inclusion of women and
> other targeted patient groups in clinical trials will be presented.
> The audience will have the opportunity to critically discuss current
> regulatory perspectives on these issues. 
> 
> 	Challenges of Drug Delivery to Targeted Patients.
> 	This section will summarize issues encountered in drug delivery
> to special population groups with emphasis on pediatric, geriatric and
> palliative care patients. Speakers will provide examples and address
> special concerns of drug delivery to these patients. This symposium
> will also include a discussion on novel advances in the use of gene
> therapy to treat diseases such as cystic fibrosis.
> 
> 	Programme, registration, and abstract/poster information is
> posted on the website.
> 	http://www.ualberta.ca/~csps
> 
> ______________________________________________________________________
> _____________________
> CSPS Call for Abstracts/Posters
> 
> "Exploring Human Diversity In Drug Development and Pharmacotherapy"
> 
> Abstracts and posters are being accepted for the 2nd Symposium of the
> Canadian Society for Pharmaceutical Sciences in Montreal, Quebec,
> Canada. The deadline for submission is June 25th, 1999, and authors
> will be informed of acceptance by July 5th, 1999. Posters presented
> elsewhere within the last 12 months are acceptable. Abstracts may be
> submitted in either English or French and must contain an adequate
> body of data with the Purpose, Methods, Results and Conclusion
> headings. The length of the poster must be between 250 to 500 words
> with the title in capital letters and the name of the presenter
> underlined. Abstracts may be submitted electronically online, or by
> email.
> 
> Work that has been presented elsewhere must be clearly acknowledged
> with the name of the meeting, the date of the original presentation,
> and referenced to the publication if abstract has been published.
> Posters will be displayed on both days of the conference, and authors
> must be present to discuss their work during all four break periods.
> To present a paper or poster, please indicate so on the Notice of
> Intention Page.
> http://www.pharmacy.ualberta.ca/CSPSConferenceSite/intention.htm  
> 
> Sandra Hutt, Administrator
> Canadian Society for Pharmaceutical Sciences
> "Journal of Pharmacy & Pharmaceutical Sciences"
> 3118 Dentistry/Pharmacy Centre
> University of Alberta Campus
> Edmonton, Alberta, Canada, T6G 2N8
> Tel: (780) 492-0950
> Fax: (780) 492-0951
> http://www.ualberta.ca/~csps
> mailto:Sandra.Hutt at ualberta.ca
> 



More information about the Diagnost mailing list